Ratings by Deutsche Bank (David Hoang)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/5/2026 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2026 | Spyre | SYRE | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2026 | Harmony Biosciences Holdings Inc. | HRMY | Downgrade | Hold (Buy) |
29.16 (28.33) |
-2.85% | Details | |
| 2/20/2026 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2026 | Alkermes | ALKS | Maintain | Buy (N/A) |
|
Details | ||
| 2/3/2026 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (N/A) |
|
Details | ||
| 12/10/2025 | Apogee Therapeutics Inc | APGE | New Coverage | Buy (N/A) |
76.09 (73.05) |
-4% | Details | |
| 12/5/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 12/1/2025 | Neurocrine Bio. | NBIX | Maintain | Hold (N/A) |
|
Details | ||
| 11/18/2025 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2025 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2025 | Alkermes | ALKS | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2025 | Neurocrine Bio. | NBIX | Maintain | Hold (N/A) |
|
Details | ||
| 10/29/2025 | Alkermes | ALKS | Maintain | Buy (N/A) |
|
Details | ||
| 10/17/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 10/3/2025 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 9/26/2025 | Spyre | SYRE | New Coverage | Buy (N/A) |
17.00 (40.15) |
136.18% | Details | |
| 9/25/2025 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Buy (N/A) |
|
Details | ||
| 9/25/2025 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2025 | Sarepta Therapeutics | SRPT | Maintain | Sell (N/A) |
|
Details | ||
| 8/7/2025 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2025 | Neurocrine Bio. | NBIX | Maintain | Hold (N/A) |
|
Details | ||
| 7/21/2025 | Sarepta Therapeutics | SRPT | Downgrade | Sell (Hold) |
21.97 (16.71) |
-23.94% | Details | |
| 7/15/2025 | Jazz Pharmaceuticals | JAZZ | New Coverage | Buy (N/A) |
110.27 (182.01) |
65.06% | Details | |
| 5/21/2025 | Acadia Pharmaceuticals | ACAD | Upgrade | Buy (Hold) |
21.99 (22.16) |
0.77% | Details | |
| 2/28/2025 | Xenon Pharmaceuticals | XENE | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2025 | Xenon Pharmaceuticals | XENE | New Coverage | Buy (N/A) |
39.21 (41.94) |
6.96% | Details | |
| 2/11/2025 | Sarepta Therapeutics | SRPT | New Coverage | Hold (N/A) |
111.82 (21.97) |
-80.35% | Details | |
| 2/11/2025 | Praxis Precision Medicines Inc. | PRAX | New Coverage | Buy (N/A) |
86.88 (310.71) |
257.63% | Details | |
| 2/11/2025 | Neurocrine Bio. | NBIX | New Coverage | Hold (N/A) |
122.62 (128.13) |
4.49% | Details | |
| 2/11/2025 | Harmony Biosciences Holdings Inc. | HRMY | New Coverage | Buy (N/A) |
37.45 (29.16) |
-22.14% | Details | |
| 2/11/2025 | Denali Therapeutics Inc. | DNLI | New Coverage | Buy (N/A) |
22.25 (19.69) |
-11.51% | Details | |
| 2/11/2025 | Biohaven Pharmaceutical Holding | BHVN | New Coverage | Buy (N/A) |
38.43 (9.92) |
-74.19% | Details | |
| 2/11/2025 | Axsome Therapeutics | AXSM | New Coverage | Buy (N/A) |
105.76 (162.33) |
53.49% | Details | |
| 2/11/2025 | Alkermes | ALKS | New Coverage | Buy (N/A) |
31.57 (28.63) |
-9.31% | Details | |
| 2/11/2025 | Acadia Pharmaceuticals | ACAD | New Coverage | Hold (N/A) |
18.55 (21.99) |
18.54% | Details | |
| 2/11/2025 | Avadel Pharmaceuticals | AVDL | New Coverage | Buy (N/A) |
8.11 (21.64) |
166.83% | Details |
